AzTrials
AzTrials

Dental CariesSTEVIANCT03724864

Edulcorants Effect in Caries Risk Schoolchildren

A study testing delivery of snacks in people with Dental Caries, run by Università degli Studi di Sassari at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This double-blind RCT aimed to evaluate the effect of sugar-free snacks on caries risk in 6-9 years-old schoolchildren. Considering a 20% difference among groups, the number of subjects needed per group was set in 87. Read more about this study

Who is it for?
Ages 6 to 8 yearsHealthy volunteers can take part
Conditions the study is for
Dental Caries
What is being tested?
delivery of snacks
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
271 participants
Where
1 siteItaly
Study dates
1 Feb 2017to 8 May 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 8 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • more than 1 initial carious lesion in the enamel (ICDAS 2-3),
  • but no manifest lesion in the dentine,
  • a salivary MS concentration ≥10^5 CFU/ml.

Who cannot join

  • Subjects with a history of systemic diseases and antibiotic therapy within 30 days before baseline were excluded.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Pediatric dentistry dept

    Sassari

Other trials in Italy

About this study

Official title: Effect of a Daily Dose of Snacks Containing Mannitol or Stevia Rebaudiana as Sweeteners in High Caries Risk Schoolchildren

This double-blind RCT aimed to evaluate the effect of sugar-free snacks on caries risk in 6-9 years-old schoolchildren. Considering a 20% difference among groups, the number of subjects needed per group was set in 87. Two-hundred-seventy-one children at risk for caries measured through Cariogram were selected and randomly assigned to three groups consuming twice a day snacks containing Stevia or Maltitol or sugar for 42 days. Parents filled out a standardized questionnaire regarding personal, medical and oral behavioural information. Bleeding on probing, plaque pH and cariogenic microflora were assessed at baseline (t0), after 21 (t1) and 42 days of snacks' use (t2) and 120 days after the end of use (t3). Cariogram was also repeated at t2.

Conditions
Dental Caries
Being tested
delivery of snacks
Medical subject headings
Dental Caries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • delivery of snacksDietary supplement

    Subjects were randomly assigned to three groups (blue, green and yellow), receiving a single type of snack for 42 days. Block randomization ensured similar proportions of participants in each group. All subjects received snack packets (six cookies each) on a weekly basis. Children were instructed to use the snack twice a day, one in the morning and one in the afternoon during lesson breaks. Both participants and investigators were blinded to the treatment assignment.

Study groups in NCT03724864
Study groupRoleWhat they receive
Stevia snacksExperimentalChildren were instructed to use the snack twice a day, one in the morning and one in the afternoon during lesson breaks.
Receives: Dietary Supplement: delivery of snacks
Maltitol snacksActive comparatorChildren were instructed to use the snack twice a day, one in the morning and one in the afternoon during lesson breaks.
Receives: Dietary Supplement: delivery of snacks
Sugared snacksPlacebo comparatorChildren were instructed to use the snack twice a day, one in the morning and one in the afternoon during lesson breaks.
Receives: Dietary Supplement: delivery of snacks

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Caries risk reduction

    calculation of the carie risk reduct using a standardised method aka "Cariogram"

    Measured: 42 days

  2. reduction of salivary cariogenic bacteria

    reduction of salivary cariogenic bacteria of one level eg from 1000000 to 10000 CFU/ml

    Measured: 42 days

Secondary outcomes (1)
  1. modification of the plaque-pH

    reduction of the Area Under the Curve (AUC) at the critical level of pH of 6.2 and 5.7

    Measured: 42 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Oct 2018
  2. Study start1 Feb 2017
  3. Primary completion30 Jun 2017
  4. Study completion8 May 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
271 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03724864
Sponsor's protocol ID
1138/L
Acronym
STEVIA
Status last verified
Oct 2018
First submitted
25 Oct 2018
Last updated
30 Oct 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing delivery of snacks in people with Dental Caries, run by Università degli Studi di Sassari at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Oct 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Caries risk reduction (time frame: 42 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2018; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in